Results 1 to 10 of about 2,539,797 (361)

Clinical Specificity of the Enzyme Immunoassay Test for Coccidioidomycosis Varies According to the Reason for Its Performance [PDF]

open access: goldClinical and Vaccine Immunology, 2013
ABSTRACT The diagnosis of coccidioidomycosis relies heavily on serologic test results in addition to clinical history, physical examination, and radiographic findings. Use of the enzyme immunoassay (EIA) has increased because it is rapidly performed and does not require referral to a reference laboratory, as do complement fixation and ...
Janis E. Blair   +4 more
semanticscholar   +4 more sources

Rapid Detection of Staphylococcus aureus Panton-Valentine Leukocidin in Clinical Specimens by Enzyme-Linked Immunosorbent Assay and Immunochromatographic Tests [PDF]

open access: bronzeJournal of Clinical Microbiology, 2010
ABSTRACT Staphylococcus aureus strains producing Panton-Valentine leukocidin (PVL) have been epidemiologically linked to specific human infections. To evaluate immunological tests that may be used to diagnose infections with PVL-producing strains, we prospectively collected pus, respiratory tract specimens, and joint ...
Hélène Meugnier   +21 more
semanticscholar   +7 more sources

Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting Helicobacter pylori [PDF]

open access: goldCanadian Journal of Gastroenterology and Hepatology, 2022
Background. BLEIA ™ “EIKEN” Helicobacter pylori antigen (B[EIA]) is based on the bioluminescent enzyme immunoassay (BLEIA) method that was newly developed with high sensitivity in detecting Helicobacter pylori (H. pylori) antigen in feces. Methods. In the project for H.
Toshihiko Kakiuchi   +3 more
openaire   +4 more sources

Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme‐linked immunosorbent assay tests for anti‐glutamic acid decarboxylase antibody in real‐world clinical practice [PDF]

open access: goldJournal of Diabetes Investigation, 2019
Anti‐glutamic acid decarboxylase antibody (GADA) is an important islet cell‐associated autoantibody for the diagnosis of autoimmune type 1 diabetes mellitus.
Yoichi Oikawa   +4 more
doaj   +2 more sources

New perspectives for use of gamma-glutamyltranspeptidase in clinical enzymes tests

open access: diamondThe Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University, 2016
Gamma-glutamyltranspeptidase (GGTP), isolated from a variety of sources from microorganisms to mammals, including human blood and organs, has been studied sufficiently detailed, which allowed to take a fresh look at the role of this enzyme in cellular metabolism, the pathogenesis of several diseases and its application in clinical medicine.
L. А. Alexandrova
openaire   +5 more sources

Clinical Correlation of a Clostridium difficile Testing Algorithm Reflexing PCR Positive Specimens to Toxin Enzyme Immunoassay (EIA) [PDF]

open access: goldOpen Forum Infectious Diseases, 2017
Abstract Background An algorithm promoted in the United Kingdom reflexes specimens positive for C. difficile by a nucleic acid amplification test (NAAT) to toxin EIA. Samples positive by NAAT and negative by toxin EIA are reported as “C. difficile could be present (ie, potential C. difficile excretor).
Carlos M. Isada   +5 more
openaire   +3 more sources

Radical-mediated Electrical Enzyme Assay For At-home Clinical Test [PDF]

open access: green
To meet the growing demand for accurate, rapid, and cost-effective at-home clinical testing, we developed a radical-mediated enzyme assay (REEA) integrated with a paper fluidic system and electrically read by a handheld field-effect transistor (FET) device. The REEA utilizes horseradish peroxidase (HRP) to catalyze the conversion of aromatic substrates
Jang, Hyun-June   +11 more
openaire   +3 more sources

Evaluation of six commercial SARS-CoV-2 Enzyme-Linked Immunosorbent assays for clinical testing and serosurveillance

open access: green, 2021
ABSTRACTBackgroundSerological testing for SARS-CoV-2 complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the COVID-19 pandemic response. As we move into the era of vaccines, the detection of neutralising antibody will become increasingly important. Many serological tests have been developed
Sharon R Lewin   +15 more
openaire   +3 more sources

The Physiological Sources of, Clinical Significance of, and Laboratory-Testing Methods for Determining Enzyme Levels [PDF]

open access: bronzeLaboratory Medicine, 2014
Enzymes are organic molecules that accelerate biochemical reactions but emerge from the reaction unchanged. Abnormal levels of plasma enzymes are highly suggestive of damaged cells and provide clues to parts of the body that may be involved in disease processes. Enzyme levels are measured in the clinical laboratory to identify the site of damage and to
Muneeza Esani
openaire   +3 more sources

Genetic Testing for Enzymes of Drug Metabolism: Does It Have Clinical Utility for Pain Medicine at the Present Time? A Structured Review [PDF]

open access: bronzePain Medicine, 2004
This is a structured review of genomic (genetic) testing for enzymes of drug metabolism.Recently, industry began offering genomic testing for enzymes of drug metabolism. As such, the objective of this review was to determine if genomic testing for enzymes of drug metabolism has any imminent clinical relevance for the practice of pain medicine.Relevant ...
R. Steele Rosomoff   +6 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy